Back to results
US 8,044,083 B2Granted
Kinase inhibitors and methods of use thereof
AssigneeArray BioPharma Inc.
InventorsRobert Groneberg, Laurence E. Burgess, Darren Harvey, Ellen Laird, Mark C. Munson, James P. Rizzi, Martha Rodriguez, Charles Todd Eary, Daniel John Watson
Life of this patent
Estimating the term…
Abstract
The compound of Formula (I) and pharmaceutically acceptable salts and prodrugs thereof are useful in the treatment and prevention of various disorders mediated by kinases.
Claims12
A compound having the Formula I:
- or a pharmaceutically acceptable salt thereof.
A compound having the Formula I in the form of a prodrug:
- or a pharmaceutically acceptable salt thereof.
2-(5-(2-((3-(3-Tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)ureido)methyl)-4-fluorophenoxy)-1H-indazol-1-yl)ethyl dihydrogenphosphate, or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.